In high-grade gliomas, SOX2 was frequently overexpressed and essential for maintenance of glioma stem cells to reinitiate and drive tumorigenicity (Gangemi et al., 2009; Ikushima et al., 2009; Hägerstrand et al., 2011). Here, SOX2 is linked to central nervous system cancer.